ABSTRACT
Background Benzodiazepine use in older adults following acute ischemic stroke (AIS) is common, yet short-term safety concerning falls or fall-related injuries remains unexplored.
Methods We emulated a hypothetical randomized trial of benzodiazepine use during the acute post stroke recovery period to assess incidence of falls or fall related injuries in older adults. Using linked data from the Get With the Guidelines Registry and Mass General Brigham’s electronic health records, we selected patients aged 65 and older admitted for Acute Ischemic Stroke (AIS) between 2014 and 2021 with no documented prior stroke and no benzodiazepine prescriptions in the previous 3 months. Potential for immortal-time and confounding biases was addressed via separate inverse-probability weighting strategies.
Results The study included 495 patients who initiated inpatient benzodiazepines within three days of admission and 2,564 who did not. After standardization, the estimated 10-day risk of falls or fall-related injuries was 694 events per 1000 (95% confidence interval CI: 676-709) for the benzodiazepine initiation strategy and 584 events per 1000 (95% CI: 575-595) for the non-initiation strategy. Subgroup analyses showed risk differences of 142 events per 1000 (95% CI: 111-165) and 85 events per 1000 (95% CI: 64-107) for patients aged 65 to 74 years and for those aged 75 years or older, respectively. Risk differences were 187 events per 1000 (95% CI: 159-206) for patients with minor (NIHSS≤ 4) AIS and 32 events per 1000 (95% CI: 10-58) for those with moderate-to-severe AIS.
Conclusions Initiating inpatient benzodiazepines within three days of AIS is associated with an elevated 10-day risk of falls or fall-related injuries, particularly for patients aged 65 to 74 years and for those with minor strokes. This underscores the need for caution with benzodiazepines, especially among individuals likely to be ambulatory during the acute and sub-acute post-stroke period.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the NIH (1R01AG073410-01)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the institutional review board of Massachusetts General Hospital, and informed consent was waived. The data that support the findings of this study are available from the corresponding author upon reasonable request and institutional approval.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* co-senior authors
Authors’ Emails: Shuo Sun: shuosun{at}hsph.harvard.edu Victor Lomachinsky: vtorres3{at}mgh.harvard.edu Louisa H. Smith: l.smith{at}northeastern.edu Joseph P. Newhouse: newhouse{at}hcp.med.harvard.edu M. Brandon Westover: bwestove{at}bidmc.harvard.edu Deborah Blacker: DBLACKER{at}mgh.harvard.edu Lee Schwamm: lee.schwamm{at}yale.edu Sebastien Haneuse: shaneuse{at}hsph.harvard.edu Lidia M.V.R. Moura: lidia.moura{at}mgh.harvard.edu
Non-standard Abbreviations and Acronyms: AIS, acute ischemic stroke; EEG, electroencephalography; CI, confidence interval; DVT, deep vein thrombosis; EHR, electronic health records; GWTG, Get With The Guidelines; IPCW, Inverse Probability of Censoring Weighting; MGB, Mass General Brigham; NIHSS, National Institute of Health Stroke Severity Scale
Data Availability
This study was approved by the institutional review board of Massachusetts General Hospital, and informed consent was waived. The data that support the findings of this study are available from the corresponding author upon reasonable request and institutional approval.
